CollPlant regained compliance with Nasdaq’s $1.00 minimum bid requirement after its ordinary shares met the threshold through September 18, 2026. Nasdaq’s confirmation formally closes the listing matter, which the company said is important to its shareholders, Business collaborators and Capital market positioning.
Key Highlights
- Nasdaq restored CollPlant’s compliance after its ordinary shares met the $1.00 minimum bid threshold.
- The qualifying closing bid prices were recorded from September 4, 2026, through September 18, 2026.
- Nasdaq formally closed the matter under Listing Rule 5550(a)(2), according to the company.
Nasdaq Confirms $1.00 Bid Requirement Met
Nasdaq staff determined that CollPlant (NASDAQ: CLGN)’s closing bid price remained at or above $1.00 per share from September 4, 2026, through September 18, 2026. Nasdaq’s notification confirmed that the continued-listing condition had been fulfilled. The matter is now formally closed.
Listing Matter Followed March Deficiency Notice
The compliance issue followed an initial Nasdaq deficiency notice dated March 23, 2026, after CollPlant’s ordinary shares traded below $1.00 per share over the preceding business days. CollPlant said maintaining its Nasdaq listing is important to business collaborators and shareholders.
FAQs
Q: What minimum bid price did CollPlant need to meet for Nasdaq compliance?
A: CollPlant needed its common stock to maintain a minimum bid price of $1.00 per share. Nasdaq confirmed that the listing requirement was satisfied.
Q: What happened to CollPlant’s Nasdaq listing matter?
A: Nasdaq formally closed the compliance matter under Listing Rule 5550(a)(2). CollPlant’s ordinary shares met the required bid-price condition.
Q: When did CollPlant’s shares meet Nasdaq’s bid threshold?
A: The qualifying period ran from September 4, 2026, through September 18, 2026. Nasdaq said the closing bid price was at or above $1.00 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.